| 发明名称 |
PULMONARY PHARMACEUTICAL FORMULATIONS |
| 摘要 |
The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment. |
| 申请公布号 |
US2016151393(A1) |
申请公布日期 |
2016.06.02 |
| 申请号 |
US201514959684 |
申请日期 |
2015.12.04 |
| 申请人 |
Civitas Therapeutics, Inc. |
发明人 |
Blizzard Charles D.;Lipp Michael M.;Ward Kevin L.;Ryznal Rachel;LeBlanc Daniel;Tracy Mark A.;Martin Rebecca |
| 分类号 |
A61K31/58;A61K38/29;A61K9/00 |
主分类号 |
A61K31/58 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A dry powder composition for administration to the respiratory system of a patient comprising biocompatible particles wherein the biocompatible particles comprise a therapeutic agent, or any combination thereof; and a hydrogenated starch hydrolysate (HSH). |
| 地址 |
Chelsea MA US |
